Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. [electronic resource]
Producer: 19900801Description: 1173-86 p. digitalISSN:- 0732-183X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bleomycin -- administration & dosage
- Dacarbazine -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Hematocrit
- Hodgkin Disease -- drug therapy
- Humans
- Lomustine -- administration & dosage
- Lymphatic Metastasis
- Male
- Mechlorethamine -- administration & dosage
- Melphalan -- administration & dosage
- Middle Aged
- Models, Biological
- Neoplasm Staging
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Prognosis
- Remission Induction
- Survival Analysis
- Vinblastine -- administration & dosage
- Vincristine -- administration & dosage
- Vindesine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.